Literature DB >> 33311894

Serum Leptin Serves as an Inflammatory Activity Marker and Predicts Steroid Response in Autoimmune Hepatitis.

Deepika Lal1, Monika Thakur1, Chhagan Bihari1.   

Abstract

BACKGROUND AND AIM: Adipocytokines, especially leptin is involved in a wide spectrum of proinflammatory functions, in various tissues. This study was carried out to assess the role of serum leptin in autoimmune hepatitis.
METHODS: Serum leptin was analyzed in treatment naïve autoimmune hepatitis (AIH, n = 48) patients and compared with the primary biliary cholangitis (PBC, n = 16), chronic hepatitis C (CHC, n = 16) and healthy controls (n = 15). Serum leptin correlation was assessed on liver function tests, disease activity, T regulatory cells (Tregs), and Th17 cells in the liver biopsies and on steroid treatment response in AIH.
RESULTS: Serum leptin was higher in AIH than in PBC, CHC, and HC {AIH: 335 (106.2-580), PBC: 126 (52-381.2), CH: 67 (3.7-133.5) and HC: 66 (40-157.5) ng/ml; P = 0.001}. In AIH cases; serum leptin correlated with hepatic activity index (r = 0.896; P < 0.001); serum transaminases (aspartate aminotransferases (AST) = 0.615, P < 0.001, alanine aminotransferases (ALT) = 0.551, P < 0.001). It had inverse correlation with Treg cells (P = -0.711, P < 0.001) and positively correlated with Th17 cells (r = 0.650, P < 0.001) in the liver biopsy tissue. High serum leptin was found to be associated with steroid partial or nonresponsiveness at 4 weeks (P = 0.002).
CONCLUSION: Serum leptin is indicative of higher AIH activity and a reduced number of Tregs cells in liver biopsy tissue. Leptin negative cases have more chances of steroid responsiveness and could help in the selection of AIH cases for appropriate therapy.
© 2020 Indian National Association for Study of the Liver. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  AIH, autoimmune hepatitis; CH, chronic hepatitis; PBC, primary biliary cholangitis; T helper cells; T regs, T regulatory cells; Th17, T helper cells; autoimmune hepatitis; leptin; liver biopsy; tregs

Year:  2020        PMID: 33311894      PMCID: PMC7719975          DOI: 10.1016/j.jceh.2020.04.014

Source DB:  PubMed          Journal:  J Clin Exp Hepatol        ISSN: 0973-6883


  24 in total

1.  Diagnosis and management of autoimmune hepatitis.

Authors:  Michael P Manns; Albert J Czaja; James D Gorham; Edward L Krawitt; Giorgina Mieli-Vergani; Diego Vergani; John M Vierling
Journal:  Hepatology       Date:  2010-06       Impact factor: 17.425

2.  An algorithm for the grading of activity in chronic hepatitis C. The METAVIR Cooperative Study Group.

Authors:  P Bedossa; T Poynard
Journal:  Hepatology       Date:  1996-08       Impact factor: 17.425

Review 3.  Systems biology in systemic lupus erythematosus: integrating genes, biology and immune function.

Authors:  Vasileios C Kyttaris; Sandeep Krishnan; George C Tsokos
Journal:  Autoimmunity       Date:  2006-12       Impact factor: 2.815

4.  Prediction of short- and long-term outcome in patients with autoimmune hepatitis.

Authors:  Martha M Kirstein; Frauke Metzler; Elena Geiger; Eyk Heinrich; Michael Hallensleben; Michael P Manns; Arndt Vogel
Journal:  Hepatology       Date:  2015-08-25       Impact factor: 17.425

5.  Acute presentation of autoimmune hepatitis: a multicentre study with detailed histological evaluation in a large cohort of patients.

Authors:  Hiep Nguyen Canh; Kenichi Harada; Hirofumi Ouchi; Yasunori Sato; Koichi Tsuneyama; Masayoshi Kage; Masayuki Nakano; Kaname Yoshizawa; Atsushi Takahashi; Masanori Abe; Jong-Hon Kang; Kazuhiko Koike; Ayano Inui; Tomoo Fujisawa; Akinobu Takaki; Teruko Arinaga-Hino; Takuji Torimura; Yoshiyuki Suzuki; Keiichi Fujiwara; Mikio Zeniya; Hiromasa Ohira; Atsushi Tanaka; Hajime Takikawa
Journal:  J Clin Pathol       Date:  2017-04-20       Impact factor: 3.411

Review 6.  Histological grading and staging of chronic hepatitis.

Authors:  K Ishak; A Baptista; L Bianchi; F Callea; J De Groote; F Gudat; H Denk; V Desmet; G Korb; R N MacSween
Journal:  J Hepatol       Date:  1995-06       Impact factor: 25.083

Review 7.  Leptin as an immunomodulator.

Authors:  Claudio Procaccini; Emilio Jirillo; Giuseppe Matarese
Journal:  Mol Aspects Med       Date:  2011-10-21

8.  The role of serum leptin levels in chronic hepatitis C with steatosis.

Authors:  Ender Ellidokuz; Abdurrahman Cömlekçi; Hülya Ellidokuz; Hale Akpinar; Cigdem Gökçe; Ethem Tankurt; Ozgül Sagol; Ilkay Simsek; Omür Gönen
Journal:  Hepatogastroenterology       Date:  2003-12

9.  Interaction of adipokines and hepatitis B virus on histological liver injury in the Chinese.

Authors:  Vincent Wai-Sun Wong; Grace Lai-Hung Wong; Jun Yu; Paul Cheung-Lung Choi; Anthony Wing-Hung Chan; Hoi-Yun Chan; Eagle Siu-Hong Chu; Alfred Sze-Lok Cheng; Angel Mei-Ling Chim; Francis Ka-Leung Chan; Joseph Jao-Yiu Sung; Henry Lik-Yuen Chan
Journal:  Am J Gastroenterol       Date:  2009-10-06       Impact factor: 10.864

10.  An assessment of serum leptin levels in patients with chronic viral hepatitis: a prospective study.

Authors:  Spilios Manolakopoulos; Sotirios Bethanis; Charis Liapi; Fotini Stripeli; Pantelis Sklavos; Alexandra Margeli; Aggeliki Christidou; Aggeliki Katsanika; Evangellos Vogiatzakis; Dimitrios Tzourmakliotis; Stamatios Theocharis
Journal:  BMC Gastroenterol       Date:  2007-05-31       Impact factor: 3.067

View more
  1 in total

1.  Leptin Enhances Hepatic Fibrosis and Inflammation in a Mouse Model of Cholestasis.

Authors:  Anca D Petrescu; Stephanie Grant; Elaina Williams; Su Yeon An; Nikhil Seth; Mark Shell; Tyson Amundsen; Christopher Tan; Yusra Nadeem; Matthew Tjahja; Lancaster Weld; Christopher S Chu; Julie Venter; Gabriel Frampton; Matthew McMillin; Sharon DeMorrow
Journal:  Am J Pathol       Date:  2021-12-08       Impact factor: 4.307

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.